281 related articles for article (PubMed ID: 23885815)
21. Combination of adjuvants: the future of vaccine design.
Mount A; Koernig S; Silva A; Drane D; Maraskovsky E; Morelli AB
Expert Rev Vaccines; 2013 Jul; 12(7):733-46. PubMed ID: 23885819
[TBL] [Abstract][Full Text] [Related]
22. Comparison between a conventional subunit vaccine and the MF59-adjuvanted subunit influenza vaccine in the elderly: an evaluation of the safety, tolerability and immunogenicity.
Sindoni D; La Fauci V; Squeri R; Cannavò G; Bacilieri S; Panatto D; Gasparini R; Amicizia D
J Prev Med Hyg; 2009 Jun; 50(2):121-6. PubMed ID: 20099444
[TBL] [Abstract][Full Text] [Related]
23. 12th Annual Conference on Vaccine Research.
O'Brien J
Expert Rev Vaccines; 2009 Sep; 8(9):1139-42. PubMed ID: 19722886
[TBL] [Abstract][Full Text] [Related]
24. Nasal vaccine innovation.
Jabbal-Gill I
J Drug Target; 2010 Dec; 18(10):771-86. PubMed ID: 21047271
[TBL] [Abstract][Full Text] [Related]
25. Adjuvants and delivery technologies.
Killeen KP
Hum Vaccin; 2009 Oct; 5(10):667-70. PubMed ID: 19556878
[No Abstract] [Full Text] [Related]
26. Mucosal adjuvants.
Harandi AM; Medaglini D
Curr HIV Res; 2010 Jun; 8(4):330-5. PubMed ID: 20353395
[TBL] [Abstract][Full Text] [Related]
27. Vaccines with the MF59 adjuvant do not stimulate antibody responses against squalene.
Del Giudice G; Fragapane E; Bugarini R; Hora M; Henriksson T; Palla E; O'hagan D; Donnelly J; Rappuoli R; Podda A
Clin Vaccine Immunol; 2006 Sep; 13(9):1010-3. PubMed ID: 16960112
[TBL] [Abstract][Full Text] [Related]
28. The development and use of vaccine adjuvants.
Edelman R
Mol Biotechnol; 2002 Jun; 21(2):129-48. PubMed ID: 12059113
[TBL] [Abstract][Full Text] [Related]
29. Adjuvants and delivery systems in veterinary vaccinology: current state and future developments.
Heegaard PM; Dedieu L; Johnson N; Le Potier MF; Mockey M; Mutinelli F; Vahlenkamp T; Vascellari M; Sørensen NS
Arch Virol; 2011 Feb; 156(2):183-202. PubMed ID: 21170730
[TBL] [Abstract][Full Text] [Related]
30. Vaccine adjuvants: current challenges and future approaches.
Wilson-Welder JH; Torres MP; Kipper MJ; Mallapragada SK; Wannemuehler MJ; Narasimhan B
J Pharm Sci; 2009 Apr; 98(4):1278-316. PubMed ID: 18704954
[TBL] [Abstract][Full Text] [Related]
31. Understanding modern-day vaccines: what you need to know.
Vetter V; Denizer G; Friedland LR; Krishnan J; Shapiro M
Ann Med; 2018 Mar; 50(2):110-120. PubMed ID: 29172780
[TBL] [Abstract][Full Text] [Related]
32. Postvaccination sarcomas in cats.
Esplin DG; McGill LD; Meininger AC; Wilson SR
J Am Vet Med Assoc; 1993 Apr; 202(8):1245-7. PubMed ID: 8496079
[No Abstract] [Full Text] [Related]
33. Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens.
Perrie Y; Mohammed AR; Kirby DJ; McNeil SE; Bramwell VW
Int J Pharm; 2008 Dec; 364(2):272-80. PubMed ID: 18555624
[TBL] [Abstract][Full Text] [Related]
34. [Novel adjuvants in vaccine development].
Kaufmann AM; Schmidt-Ott R; Prechtl A
MMW Fortschr Med; 2011 Jan; 153(1-2):44. PubMed ID: 24761492
[No Abstract] [Full Text] [Related]
35. Vaccine adjuvants: a priority for vaccine research.
Harandi AM; Medaglini D; Shattock RJ;
Vaccine; 2010 Mar; 28(12):2363-6. PubMed ID: 20064476
[TBL] [Abstract][Full Text] [Related]
36. Laser vaccine adjuvants. History, progress, and potential.
Kashiwagi S; Brauns T; Gelfand J; Poznansky MC
Hum Vaccin Immunother; 2014; 10(7):1892-907. PubMed ID: 25424797
[TBL] [Abstract][Full Text] [Related]
37. Vaccine safety in the neonatal period.
Day MJ
J Comp Pathol; 2007 Jul; 137 Suppl 1():S51-6. PubMed ID: 17561085
[TBL] [Abstract][Full Text] [Related]
38. Nonclinical safety assessment of vaccines and adjuvants.
Wolf JJ; Kaplanski CV; Lebron JA
Methods Mol Biol; 2010; 626():29-40. PubMed ID: 20099119
[TBL] [Abstract][Full Text] [Related]
39. Vaccinated fish welfare: protection versus side-effects.
Midtlyng PJ
Dev Biol Stand; 1997; 90():371-9. PubMed ID: 9270866
[TBL] [Abstract][Full Text] [Related]
40. [Vaccines: intradermal, poliomyelitis, aluminum].
Nau JY
Rev Med Suisse; 2012 Nov; 8(364):2308-9. PubMed ID: 23240250
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
